Huda Farid Al Akrabi, Datius Mutalemwa, Kajiru Kilonzo, Abel Mwanga
Background
Colchicine is widely used for the treatment of acute gout ares due to its anti-inammatory properties. Beyond this traditional role, colchicine has been implicated in modulating various physiological systems, including glucose metabolism. Notably, it exhibits a biphasic effect on blood glucose levels causing hypoglycemia at lower doses and hyperglycemia at higher doses. However, its impact on glycemic control in diabetic patients undergoing dialysis remains poorly characterized
